Difference between revisions of "Part:BBa K3030001"
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
+ | __NOTOC__ | ||
+ | <partinfo>BBa_K3030001 short</partinfo> | ||
+ | |||
+ | This basic part is EAAT2 RNA which can translate into EAAT2 protein that is a member of a family of the solute carrier family of proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. EAAT2 is responsible for over 90% of glutamate reuptake within the brain. | ||
+ | |||
+ | <!-- Add more about the biology of this part here | ||
+ | ===Usage and Biology=== | ||
+ | |||
+ | <!-- --> | ||
+ | <span class='h3bb'>Sequence and Features</span> | ||
+ | <partinfo>BBa_K3030001 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | <!-- Uncomment this to enable Functional Parameter display | ||
+ | ===Functional Parameters=== | ||
+ | <partinfo>BBa_K3030001 parameters</partinfo> | ||
+ | <!-- --> | ||
+ | <p class=”text”><h3>Reference</h3></p> | ||
+ | <br> | ||
+ | Kanai, Y. and Hediger, M. A. (2003) ‘The glutamate and neutral amino acid transporter family : physiological and pharmacological implications’,<i>European Journal of Pharmacology</i>, 479(1–3), pp. 237–247. doi: 10.1016/j.ejphar.2003.08.073. |
Latest revision as of 22:19, 21 October 2019
EAAT2-RNA
This basic part is EAAT2 RNA which can translate into EAAT2 protein that is a member of a family of the solute carrier family of proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. EAAT2 is responsible for over 90% of glutamate reuptake within the brain.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 35
Illegal PstI site found at 1329 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 35
Illegal PstI site found at 1329 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 35
Illegal PstI site found at 1329 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 35
Illegal PstI site found at 1329 - 1000COMPATIBLE WITH RFC[1000]
Reference
Kanai, Y. and Hediger, M. A. (2003) ‘The glutamate and neutral amino acid transporter family : physiological and pharmacological implications’,European Journal of Pharmacology, 479(1–3), pp. 237–247. doi: 10.1016/j.ejphar.2003.08.073.